DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Riva N, Mora G, Sorarù G. et al
Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
The Lancet Neurology 2019;
18: 155-164
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.